Latest Market Research Report 2025

  The global  drug device combination products market  size is expected to reach USD 251.87 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive techniques due to enhanced patient outcomes associated with it is the high impact-rendering driver of this market. These devices facilitate early diagnosis and reduce treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.   Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamli...

  Drug Device Combination Products   Industry Overview The global drug device combination products market size was estimated at USD 138.47 billion in 2023 and is projected to grow at a CAGR of 9.0% from 2024 to 2030. Technological advancements, increasing demand for minimally invasive drug delivery devices, increasing prevalence of chronic diseases such as diabetes, and the rising geriatric population are the major factors anticipated to propel market growth over the forecast period. According to the International Diabetes Federation (IDF), an estimated 537 million adults in the age group 20-79 were affected with diabetes in 2021, and this number is expected to grow to 783 million by 2045. The International Diabetes Federation (IDF) further stated that an estimated 90% of people with diabetes are at an elevated risk of developing type 2 diabetes. Gather more insights about the market drivers, restrains and growth of the   Drug Device Combination Market The indus...